United States · FDA National Drug Code directory
Reltone 200 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80056-143_1fc18c67-20db-4fe5-bc22-2772f0788d13
- Product NDC
- 80056-143
- Form
- CAPSULE
- Composition / generic term
- Ursodiol
- Labeler
- Intra-Sana Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200701
- Source listing expiry
- 20261231
Source-listed ingredients
- URSODIOL — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (80056-143-01) · 80056-143-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →